Encorafenib, Binimetinib, and Cetuximab in <i>BRAF</i> V600E–Mutated Colorectal CancerScott Kopetz, Josep Tabernero, Ashwin Gollerkeri et al.|New England Journal of Medicine|2019Cited by 1.5k
Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 studyRichard Fox, Daniel H. Palmer, Hassan Malik et al.|The Lancet Oncology|2019Cited by 1.2k
Guidelines for the diagnosis and treatment of cholangiocarcinoma: an updateShahid A. Khan, Harpreet Wasan, Brian R Davidson et al.|Gut|2012Cited by 792
Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus documentShahid A. Khan, Harpreet Wasan, Brian R Davidson et al.|Gut|2002Cited by 645
Axitinib plus gemcitabine versus placebo plus gemcitabine in patients with advanced pancreatic adenocarcinoma: a double-blind randomised phase 3 studyHedy L. Kindler, Eric Van Cutsem, Tatsuya Ioka et al.|The Lancet Oncology|2011Cited by 396